Simufilam

Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers

Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Open-label Extension for Phase 3 Clinical Trials of Simufilam